The cyclin dependent kinase inhibitor (R)-roscovitine mediates selective suppression of alloreactive human T cells but preserves pathogen-specific and leukemia-specific effectors

Copyright © 2014 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 152(2014), 1-2 vom: 01. Mai, Seite 48-57
1. Verfasser: Nellore, Anoma (VerfasserIn)
Weitere Verfasser: Liu, Bianling, Patsoukis, Nikolaos, Boussiotis, Vassiliki A, Li, Lequn
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2014
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Cdk2 Graft versus host disease T cells T regulatory cells Protein Kinase Inhibitors Purines WT1 Proteins mehr... WT1 protein, human Roscovitine 0ES1C2KQ94 Interferon-gamma 82115-62-6 EZH2 protein, human EC 2.1.1.43 Enhancer of Zeste Homolog 2 Protein Polycomb Repressive Complex 2 Cyclin-Dependent Kinase 2 EC 2.7.11.22